IntroductionBruton’s tyrosine kinase (BTK) is at the core of present day treatment in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) which in turn is redefining first line and ...

In this issue, Ferrante et al 3 led semistructured interviews with 32 lymphoma survivors and 13 lymphoma oncologists and advanced practice nurses to understand and characterize survivors' care ...

Hodgkin lymphoma and primary mediastinal B-cell lymphoma are two aggressive blood cancers that affect young people between their late teens and mid-30s, a group often referred to as Adolescents and ...

Experts look back on the year in the news regarding bispecific antibodies for the treatment of B-cell lymphomas including CLL and SLL. The biggest news of 2023 for patients with lymphoma and provers ...

Not all cancers respond to the same treatments or have the same genetic origins. Epstein–Barr virus (EBV), a common and ...

The goal of follicular lymphoma treatment is to put your disease into remission. That means your symptoms, and signs doctors look for on scans, diminish or disappear. You can stay in remission for ...

The cutaneous T-cell lymphoma clinical trial analysis report delivers important insights into ongoing research of 30+ ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. Actor Jeff Bridges has said he feels "terrific" after going into remission after being diagnosed with a type of cancer ...

Ashwin Pranjapye, a 55-year-old man, faced severe abdominal issues and weight loss. Doctors diagnosed him with advanced ...

Clemson redshirt sophomore defensive tackle Hevin Brown-Shuler will undergo treatment following confirmation of a Hodgkin ...